Product finder

Classical Monocyte Isolation Kit

Our solution for the fastest untouched isolation of CD14+CD16– monocytes from human PBMCs.

November 1, 2017

AstroMACS Medium

Experience serum-free cultivation of primary neonatal and adult mouse astrocytes with low seeding density.

November 1, 2017

AstroMACS Separation Buffer

Removing dead cells during separation to ensure the cultivation of healthy adult astrocytes.

November 1, 2017
Neural cell specific primary antibodies

Antibodies suitable for ICC or IHC staining of astrocytes, oligodendrocytes, microglia, neuronal stem cells and neurons.

October 1, 2017

New: MACSQuant® X revolutionizes high-throughput flow cytometry

Miltenyi Biotec is launching a new era in the field of fully automated high-throughput flow cytometry analysis: Now up to 384-well plates can be handled in less than 60 minutes giving users fast, reliable, and reproducible results. This is made possible by the MACSQuant® X – a benchtop instrument that gives you all the flexibility and is easy to use.

September 14, 2017

Natural Killer Cells: Cultivation, Activation and Growth

Miltenyi Biotec extends its product portfolio in the area of cell culture media with the NK MACS® Medium

August 4, 2017

Miltenyi Biotec named as an employer for the future

In its current issue, the news magazine “Focus” has published the results of a survey with the title “Germany’s best jobs with a future“.

July 3, 2017

New: MACS® GMP T Cell TransAct™ from Miltenyi Biotec

MACS® GMP T Cell TransAct™ is a ready-to-use reagent for efficient in vitro activation and expansion of human T cells. Also available in research grade.

April 20, 2017
Cell Therapy Manufacturing & Gene Therapy Congress
Amsterdam, Netherlands - December 6-7
59th ASH Annual Meeting & Exposition
Atlanta, GA, USA - December 9-12

Customer login

Go

Forgot password?
Register for account

0 Shopping cart

Contact

Miltenyi Biotec Inc.
Phone: +1 800 FOR MACS
Fax:+1 877 591 1060
macs@miltenyibiotec.com
Contact overview

Product finder

Antibody panel builder

Toolbox

Loading...
Your opinion matters

Your opinion matters

Change country

Please select your country to continue